BTIG Reiterates a Buy Rating on Irhythm Technologies (IRTC)

BTIG analyst Marie Thibault reiterated a Buy rating on Irhythm Technologies (IRTCResearch Report) today and set a price target of $155.00. The company’s shares closed last Monday at $142.31.

According to TipRanks.com, Thibault is a 4-star analyst with an average return of 6.5% and a 31.5% success rate. Thibault covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings, Edwards Lifesciences, and Boston Scientific.

Irhythm Technologies has an analyst consensus of Moderate Buy, with a price target consensus of $155.14, representing a 6.8% upside. In a report issued on July 8, Truist Financial also maintained a Buy rating on the stock with a $165.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

The company has a one-year high of $169.54 and a one-year low of $41.66. Currently, Irhythm Technologies has an average volume of 424.1K.

Based on the recent corporate insider activity of 33 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of IRTC in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

iRhythm Technologies, Inc. is a commercial-stage digital healthcare company, which engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. It offers ZIO which diagnose many arrhythmias, avoiding multiple indeterminate tests, allowing for appropriate medical intervention, and prevents serious downstream medical events. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.

Read More on IRTC:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed